DK0520879T3 - 16-methylsubstituerede derivater af pregna-1,4-dien-3,20-dion, deres fremstilling, deres anvendelse til fremstilling af 16-methylensteroider og hidtil ukendte mellemprodukter - Google Patents
16-methylsubstituerede derivater af pregna-1,4-dien-3,20-dion, deres fremstilling, deres anvendelse til fremstilling af 16-methylensteroider og hidtil ukendte mellemprodukterInfo
- Publication number
- DK0520879T3 DK0520879T3 DK92401764.3T DK92401764T DK0520879T3 DK 0520879 T3 DK0520879 T3 DK 0520879T3 DK 92401764 T DK92401764 T DK 92401764T DK 0520879 T3 DK0520879 T3 DK 0520879T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- methyl
- pregna
- dione
- diene
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- QIEPWCSVQYUPIY-LEKSSAKUSA-N Delta(1)-progesterone Chemical class C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QIEPWCSVQYUPIY-LEKSSAKUSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- -1 formyloxy Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9107784A FR2678275B1 (fr) | 1991-06-25 | 1991-06-25 | Nouveaux sterouides 16-methyl substitue derives de la pregna 1,4-diene 3,20-dione leur preparation, leur application a la preparation de sterouides 16-methylene et nouveaux intermediaires. |
| CN92105005A CN1035948C (zh) | 1991-06-25 | 1992-06-25 | 孕甾-1，4-二烯-3，20-二酮衍生物的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0520879T3 true DK0520879T3 (da) | 1997-10-20 |
Family
ID=36781528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92401764.3T DK0520879T3 (da) | 1991-06-25 | 1992-06-24 | 16-methylsubstituerede derivater af pregna-1,4-dien-3,20-dion, deres fremstilling, deres anvendelse til fremstilling af 16-methylensteroider og hidtil ukendte mellemprodukter |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5248773A (enExample) |
| EP (1) | EP0520879B1 (enExample) |
| JP (1) | JP3037508B2 (enExample) |
| KR (1) | KR100220540B1 (enExample) |
| CN (1) | CN1035948C (enExample) |
| AT (1) | ATE152119T1 (enExample) |
| AU (1) | AU646342B2 (enExample) |
| CA (1) | CA2072053C (enExample) |
| DE (1) | DE69219217T2 (enExample) |
| DK (1) | DK0520879T3 (enExample) |
| ES (1) | ES2100315T3 (enExample) |
| FR (1) | FR2678275B1 (enExample) |
| GR (1) | GR3023294T3 (enExample) |
| HU (1) | HU213674B (enExample) |
| MX (1) | MX9202972A (enExample) |
| RU (1) | RU2099346C1 (enExample) |
| ZA (1) | ZA924665B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU226413B1 (en) * | 1991-06-25 | 2008-11-28 | Aventis Pharma Sa | Novel 16-(nitro-substituted methyl)pregna-1,4-dien-3,20-dion derivatives and process for producing them |
| FR2692266B1 (fr) * | 1992-06-11 | 1994-08-05 | Roussel Uclaf | Nouveau procede de preparation de sterouides 16 alpha-methyles. |
| CN1061984C (zh) * | 1996-04-18 | 2001-02-14 | 上海华联制药有限公司 | 甾体激素化合物中引入9-11双键的一种方法 |
| DK2444092T3 (en) | 2008-05-28 | 2015-09-28 | Reveragen Biopharma Inc | Non-hormonal steroidmodulatorer of NF-? B for the treatment of disease |
| EP2556083A4 (en) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
| WO2017004205A1 (en) | 2015-06-29 | 2017-01-05 | Reveragen Biopharma, Inc. | NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0104054A3 (en) * | 1982-09-20 | 1985-10-09 | The Upjohn Company | 16-methylene-steroids and their preparation |
| DE3486450T2 (de) * | 1984-01-05 | 1997-11-06 | Pharmacia & Upjohn Co., Kalamazoo, Mich. | 17-Alpha-Ethynyl Steroide |
-
1991
- 1991-06-25 FR FR9107784A patent/FR2678275B1/fr not_active Expired - Fee Related
-
1992
- 1992-06-18 MX MX9202972A patent/MX9202972A/es unknown
- 1992-06-23 CA CA002072053A patent/CA2072053C/fr not_active Expired - Lifetime
- 1992-06-24 EP EP92401764A patent/EP0520879B1/fr not_active Expired - Lifetime
- 1992-06-24 HU HU9202100A patent/HU213674B/hu unknown
- 1992-06-24 DK DK92401764.3T patent/DK0520879T3/da active
- 1992-06-24 ZA ZA924665A patent/ZA924665B/xx unknown
- 1992-06-24 ES ES92401764T patent/ES2100315T3/es not_active Expired - Lifetime
- 1992-06-24 RU SU925011969A patent/RU2099346C1/ru active
- 1992-06-24 AU AU18478/92A patent/AU646342B2/en not_active Ceased
- 1992-06-24 KR KR1019920010983A patent/KR100220540B1/ko not_active Expired - Lifetime
- 1992-06-24 DE DE69219217T patent/DE69219217T2/de not_active Expired - Lifetime
- 1992-06-24 JP JP4188932A patent/JP3037508B2/ja not_active Expired - Lifetime
- 1992-06-24 AT AT92401764T patent/ATE152119T1/de active
- 1992-06-25 CN CN92105005A patent/CN1035948C/zh not_active Expired - Fee Related
- 1992-06-25 US US07/903,886 patent/US5248773A/en not_active Expired - Lifetime
-
1997
- 1997-04-30 GR GR960402901T patent/GR3023294T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU213674B (en) | 1997-09-29 |
| JPH05186496A (ja) | 1993-07-27 |
| ATE152119T1 (de) | 1997-05-15 |
| AU1847892A (en) | 1993-01-07 |
| JP3037508B2 (ja) | 2000-04-24 |
| KR100220540B1 (ko) | 1999-10-01 |
| RU2099346C1 (ru) | 1997-12-20 |
| FR2678275B1 (fr) | 1995-06-23 |
| AU646342B2 (en) | 1994-02-17 |
| GR3023294T3 (en) | 1997-07-30 |
| CA2072053C (fr) | 2003-10-21 |
| EP0520879B1 (fr) | 1997-04-23 |
| ZA924665B (en) | 1993-06-24 |
| EP0520879A2 (fr) | 1992-12-30 |
| DE69219217D1 (de) | 1997-05-28 |
| US5248773A (en) | 1993-09-28 |
| CN1035948C (zh) | 1997-09-24 |
| HUT61569A (en) | 1993-01-28 |
| HU9202100D0 (en) | 1992-10-28 |
| CA2072053A1 (fr) | 1992-12-26 |
| MX9202972A (es) | 1993-04-01 |
| DE69219217T2 (de) | 1997-11-13 |
| ES2100315T3 (es) | 1997-06-16 |
| FR2678275A1 (fr) | 1992-12-31 |
| KR930000534A (ko) | 1993-01-15 |
| EP0520879A3 (enExample) | 1995-04-12 |
| CN1068120A (zh) | 1993-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8802429A1 (es) | Un procedimiento para la preparacion de androsta-1,4-dien-3,17-dionas | |
| ZA924665B (en) | Substituted 16-methyl steroid derivatives of pregna-1, 4-dien-3,20-doine, their preparation, their use in the preparation of 16-methylene steroids and intermediates. | |
| AU589269B2 (en) | New 6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation | |
| DK0515264T3 (da) | Hidtil ukendte steroid-derivater af pregna-4,9(11),17(20)-trien-3-on, deres fremstilling, deres anvendelse til fremstilling af steroidforbindelser af typen pregna-4,9(11),16-trien-3,20-dion samt hidtil ukendte mellemprodukter | |
| SE8105686L (sv) | Nya 17-oxazolin-steroidderivat, sett for framstellning derav och anvendning derav vid framstellning av kortikosteroider | |
| DK0469548T3 (da) | 4-Amino-delta4-steroider og deres anvendelse som inhibitorer af 5alfa-reduktase | |
| DE69126622D1 (de) | 2beta,19-methylenamin überbrückte steroide als aromatasehemmer | |
| NO20020260L (no) | 11<beta>-aryl-17,17-spirotiolansubstituerte steroider | |
| DE60331572D1 (de) | Stereospezifische reduktion von sapogen-3-onen | |
| ES8603910A1 (es) | Procedimiento para la obtencion del ester 2-hidroxibenzoico en c-21 de un esteroide pregnanico clorado | |
| NO944124L (no) | 17 yre |